A recent study also indicates that levels of ROS of lung cancer cells are associated with the alteration of pAMPKα [34], while AMPK activation is associated with protein synthesis [24, 25], which is controlled by Brf1 and Pol III genes. The gene discussed is BRF1; the disease is lung carcinoma.